All filters
Videos
Imaging Drug Disposition in Tissues for PK/PD
Antiviral PK 2021 Session 4: Innovative Approaches for Antiviral Pharmacology Day 2 | 21 September Title: Imaging Drug Disposition in Tissues for PK/PD Presenter: Elias Rosen
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Debate: TAF versus TDF - TDF Advocate
Antiviral PK 2021 Session 5: Debate: TAF versus TDF Day 2 | 21 September Title: Debate: TAF versus TDF - TDF Advocate Presenter: José Castillo Mancilla
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA Regimens
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA Regimens Presenter: Charles Flexner
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and Rilpivirine
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and Rilpivirine Presenter: Parul PatelÂ
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
DDIs
Antiviral PK 2021 Session 7: Live Panel Discussion on LA Day 2 | 21 September Title: DDIs Presenter: Catia Marzolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Pharmacological Considerations for Special Populations
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September Title: PrEP Benchmarks – Can They Cover All Populations – Pregnancy? Presenter: Peter Anderson
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Immune Checkpoint Inhibitors in the Treatment of HBV
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September Title: Immune Checkpoint Inhibitors in the Treatment of HBV Presenter: Debika Bhattacharya
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Pharmacologically Focused to Optimize HIV Prevention for Transgender Women
Antiviral PK 2021 Session 8: Pharmacological Considerations for Special Populations Day 3 | 22 September
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Charles Boucher Memorial Lecture
Antiviral PK 2021 | Charles Boucher Memorial Lecture | Angela Kashuba
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Small Molecules and mAbs as Antiviral Therapy for COVID-19
Antiviral PK 2021 Session 1: Clinical Pharmacology of COVID-19 Day 1 | 20 September
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Slidesets
Pharmacological Management of Complex Patients
Antiviral PK 2021 Session 1: Clinical Pharmacology of COVID-19 Day 1 | 20 September
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIV
Tackling the Immune System in Patients With COVID-19
Andrea Calcagno, MD, DTM&H
Unit of Infectious Diseases, Department of Medical Sciences, University of Turin
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Leveraging Reverse Transcriptase in HIV 2021 - Laura Waters
Presented at:
Leveraging Reverse Transcriptase in HIV 2021
Meeting Report
Meeting Report Day 3 | V. Bukkems | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 2 | J. Castillo-Mancilla | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Thakkar | | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | V. Bukkems | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | M. Ferrara | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | S. Khoo | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | N. Sheehan | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | L. Walker | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Meeting Report
Meeting Report Day 1 | D. Hodge | by M. Mascolini
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Gilead: RSV | Erik Mogalian
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Janssen: Influenza | Thomas Kakuda, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017